Quality of life with durvalumab in stage III non-small-cell lung cancer
Related Experiment Video
Updated: Jan 6, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Amélie Anota1, Virginie Westeel2
1Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, 25 000 Besançon, France; INSERM UMR 1098 (Host-Graft-Tumour Interactions and Cell and Tissue Engineering), University of Franche-Comté, Besançon, France; French National Platform Quality of Life and Cancer, Besançon, France.
No abstract available in PubMed .
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Related Concept Videos
Treatment Resistant Cancers
Asthma-III: Symptoms and Complications
Classification of Asthma
Tumor Immunotherapy
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History